# Endocrine Agents: Uterine Fibroids

**LENGTH OF AUTHORIZATIONS:**   180 Days

Patients who have been treated with Oriahnn or Myfembree for 720 days or more are not eligible for additional authorizations

Patients who have been treated with Lupron Depot for 180 days or more are not eligible for additional authorizations

**PRIOR AUTHORIZATION CRITERIA:**

1. Is there any reason the patient cannot be changed to a medication not requiring prior approval?

    Acceptable reasons include:

    - Allergy to medications not requiring prior approval

    - Contraindication to or drug interaction with medications not requiring prior approval

    - History of unacceptable/toxic side effects to medications not requiring prior approval

2. The requested medication may be approved if the patient has a diagnosis of uterine leiomyomas (fibroids) and has failed a 90 day or more trial with an oral contraceptive

## Uterine Fibroids

| Endocrine Agents: Uterine Fibroids        |               |
|-------------------------------------------|---------------|
| PREFERRED                                 | NON-PREFERRED |
| Lupron Depot PA 3.75, 11.25mg             | Myfembree     |
| Oriahnn PA                                |               |

**Link to Criteria:** [Endocrine Agents: Uterine Fibroids](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=57)
